Atlas Trials

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Clinical trial NCT01436045 · COMPLETED

Trial details

NCT number
NCT01436045
Sponsor
HealthPartners Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2011-09-01
Primary completion
2013-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.